Seeking Alpha

The FDA won't appeal a decision to overturn the conviction of a salesmen who was found guilty of...

The FDA won't appeal a decision to overturn the conviction of a salesmen who was found guilty of marketing narcolepsy drug Xyrem for treating drowsiness and chronic fatigue, two conditions for which the medicine wasn't approved. A court quashed the conviction because it said FDA regulations violated free speech in a decision that could have wide ramifications for the agency's ability to regulate off-label drug marketing.
From other sites
Comments (3)
  • MikeInRI
    , contributor
    Comments (18) | Send Message
    So this court is saying its okay to permit fraud as a matter of free-speech? As long as a private citizen can still sue this individual for committing this fraud I agree with this decision of the court - otherwise what a load of crap.
    24 Jan 2013, 05:17 AM Reply Like
  • funguide
    , contributor
    Comments (48) | Send Message
    This individual is selling a drug, since all drugs are approved by the FDA for treating some condition which they specify and this individual is lying about the conditions this drug can treat; His lie doesn't won't help the public in any way, I don't see how free speech is violated. LOADS OF CRAP.
    24 Jan 2013, 11:28 AM Reply Like
  • R Markle
    , contributor
    Comment (1) | Send Message
    Good decision. Off label uses for drugs are used all the time, like Wellbutrin, an antidepressant, is prescribed to help people quit smoking. Leave the prescriptions to the Docs.
    24 Jan 2013, 03:04 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs